Found 37 matching trials
The Effects of Urinary pH Changes on an Investigational Compound in Healthy Subjects PHASE1 This study is designed to explore the effect of increased and decreased uri...
Show More Location
For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559), Mon - Fri, from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST) or speak with your personal physician.
Learn More & Join Trial
The Effect of Bicarbonate Profiling in Dialysis Fluid on Phosphate Removal During Hemodialysis and Blood pH NA Hyperphosphatemia is still an unresolved problem among hemodialysis patient...
Show More Learn More & Join Trial
Modified Atraumatic Restorative Treatment Using CPP ACP NA To evaluate the clinical and radiographic success of using Casein Phosphope...
Show More Location
Multiple Locations
Learn More & Join Trial
Ruxolitinib and Chemotherapy in Adolescents and Young Adults With Ph-like Acute Lymphoblastic Leukemia PHASE1 This study will test if adding ruxolitinib to standard multi-drug chemother...
Show More Location
University of Chicago Medical Center
Learn More & Join Trial
Feasibility of Mid-frequency Ventilation in Newborns With RDS: Randomized Crossover Pilot Trial PHASE1 Respiratory distress syndrome (RDS) is the most common respiratory disorder...
Show More Location
University of Alabama at Birmingham
Learn More & Join Trial
Work of Breathing in Bronchiolitis Under Non-invasive Ventilation NA Severe acute viral bronchiolitis is the leading cause of pediatric intensiv...
Show More Location
Hôpital Necker-Enfants Malades
Learn More & Join Trial
SKIN Disease Profiling by an Exploratory, pRospective, Biomarker Study in dermatoloGY Practice (SKINERGY) N/A The goal of this observational study is to comprehensively profile six immu...
Show More Location
Radboud University Medical Center
Learn More & Join Trial
EWSs and 28-Day Mortality in Geriatric ED Patients N/A This prospective observational cohort study evaluated the prognostic perfor...
Show More Location
Haseki Training and Research Hospital
Learn More & Join Trial
First Time in Human (FTIH) Safety and Pharmacokinetics (PK) Study of GSK3036656 in Healthy Subjects PHASE1 GSK3036656 is being developed by GSK for the treatment of tuberculosis (TB)...
Show More Location
GSK Investigational Site
Learn More & Join Trial
A Study of Fedratinib With IDH Inhibition in Advanced-Phase, IDH-Mutated Ph-Negative Myeloproliferative Neoplasms PHASE1 The purpose of this research is to gather information on the safety and eff...
Show More Location
University of Chicago Medical Center
Learn More & Join Trial